ArticlemedRxiv : the preprint server for health sciences2024
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound.
Shadisadat Esmaeili et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.